Neuraptive Therapeutics Announces Key Organizational Updates to Support Progress Toward Commercialization

Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Advance Its Path Toward Commercialization Neuraptive Therapeutics has announced two key leadership appointments aimed at strengthening both its corporate governance and financial…

Read MoreNeuraptive Therapeutics Announces Key Organizational Updates to Support Progress Toward Commercialization

Ignite Proteomics Launches 10,000-Patient Oncology Registry to Study Functional Proteomics in Cancer Therapy Selection

Ignite Proteomics Launches Prospective 10,000-Patient Oncology Registry to Assess Functional Proteomics in Cancer Therapy Selection Ignite Proteomics, LLC (“Ignite Proteomics”), a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), has announced the…

Read MoreIgnite Proteomics Launches 10,000-Patient Oncology Registry to Study Functional Proteomics in Cancer Therapy Selection